X-84361503-A-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001177479.2(HDX):āc.1415T>Cā(p.Val472Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000663 in 1,206,585 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes š: 0.0000055 ( 0 hom. 0 hem. )
Consequence
HDX
NM_001177479.2 missense
NM_001177479.2 missense
Scores
1
9
7
Clinical Significance
Conservation
PhyloP100: 7.17
Genes affected
HDX (HGNC:26411): (highly divergent homeobox) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. Predicted to be part of chromatin. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3267101).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HDX | NM_001177479.2 | c.1415T>C | p.Val472Ala | missense_variant | 6/11 | ENST00000373177.3 | NP_001170950.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HDX | ENST00000373177.3 | c.1415T>C | p.Val472Ala | missense_variant | 6/11 | 1 | NM_001177479.2 | ENSP00000362272 | P1 | |
HDX | ENST00000297977.9 | c.1415T>C | p.Val472Ala | missense_variant | 5/10 | 1 | ENSP00000297977 | P1 | ||
HDX | ENST00000506585.6 | c.1241T>C | p.Val414Ala | missense_variant | 5/10 | 2 | ENSP00000423670 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111966Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34142
GnomAD3 genomes
AF:
AC:
2
AN:
111966
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34142
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000554 AC: 1AN: 180613Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 65281
GnomAD3 exomes
AF:
AC:
1
AN:
180613
Hom.:
AF XY:
AC XY:
0
AN XY:
65281
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000548 AC: 6AN: 1094619Hom.: 0 Cov.: 27 AF XY: 0.00 AC XY: 0AN XY: 360193
GnomAD4 exome
AF:
AC:
6
AN:
1094619
Hom.:
Cov.:
27
AF XY:
AC XY:
0
AN XY:
360193
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111966Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34142
GnomAD4 genome
AF:
AC:
2
AN:
111966
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34142
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 06, 2022 | The c.1415T>C (p.V472A) alteration is located in exon 6 (coding exon 4) of the HDX gene. This alteration results from a T to C substitution at nucleotide position 1415, causing the valine (V) at amino acid position 472 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
T;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;N
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;.
REVEL
Uncertain
Sift
Benign
T;.;.
Sift4G
Benign
T;T;T
Polyphen
P;.;P
Vest4
MutPred
Loss of catalytic residue at V472 (P = 0.022);.;Loss of catalytic residue at V472 (P = 0.022);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at